[HTML][HTML] Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review

P Manganotti, G Garascia, G Furlanis… - Frontiers in …, 2023 - frontiersin.org
Introduction Among the clinical manifestations of SARS-CoV-2 infection, neurological
features have been commonly reported and the state-of-the-art technique suggests several …

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review.

P Manganotti, G Garascia, G Furlanis - Frontiers in Neuroscience, 2023 - europepmc.org
Methods We explored the indexed medical literature in order to answer the question of
whether IVIg could be included as a valid weapon in the therapeutic arsenal against COVID …

[HTML][HTML] Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review

P Manganotti, G Garascia, G Furlanis… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods We explored the indexed medical literature in order to answer the question of
whether IVIg could be included as a valid weapon in the therapeutic arsenal against COVID …

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review

P Manganotti, G Garascia… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Among the clinical manifestations of SARS-CoV-2 infection, neurological
features have been commonly reported and the state-of-the-art technique suggests several …

Effcacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review.

P Manganotti, G Garascia, G Furlanis… - Frontiers in …, 2023 - search.ebscohost.com
Introduction: Among the clinical manifestations of SARS-CoV-2 infection, neurological
features have been commonly reported and the state-of-the-art technique suggests several …

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review

P Manganotti, G Garascia, G Furlanis… - FRONTIERS IN …, 2023 - arts.units.it
Introduction: Among the clinical manifestations of SARS-CoV-2 infection, neurological
features have been commonly reported and the state-of-the-art technique suggests several …

[PDF][PDF] E cacy of intravenous immunoglobulin (IVIg) on COVID--related neurological disorders over the last years: an

P Manganotti, G Garascia, G Furlanis, AB Stella - scienceopen.com
Results: Virtually, all reviewed studies were in agreement of detecting an acceptable to great
e cacy upon IVIg employment in neurological diseases, with no or mild adverse e ects. In the …

[PDF][PDF] E cacy of intravenous immunoglobulin (IVIg) on COVID--related neurological disorders over the last years: an

P Manganotti, G Garascia, G Furlanis, AB Stella - arts.units.it
Results: Virtually, all reviewed studies were in agreement of detecting an acceptable to great
e cacy upon IVIg employment in neurological diseases, with no or mild adverse e ects. In the …

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review.

P Manganotti, G Garascia, G Furlanis - Frontiers in Neuroscience, 2023 - europepmc.org
Methods We explored the indexed medical literature in order to answer the question of
whether IVIg could be included as a valid weapon in the therapeutic arsenal against COVID …